Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control study.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
S E BeekmannG V Doern

Abstract

The objective of the case-control study presented here was to examine the risk factors for macrolide-resistant Streptococcus pneumoniae. As part of a 44-center U.S. surveillance study, 1,817 unique isolates of S. pneumoniae were collected from November 2002 through April 2003. Seventy-five randomly selected macrolide-resistant isolates (cases) were each matched with one susceptible control. Macrolide use in the 6 weeks prior to sample collection was reported for seven cases and one control. The final conditional logistic regression model identified two statistically significant variables: a history of alcohol abuse was protective, while macrolide use in the 6 weeks prior to sample collection was a significant risk factor for macrolide-resistant S. pneumoniae. Macrolide resistance was associated with use of any antibiotic during the prior 6 weeks, and was most strongly associated with previous macrolide use.

References

Mar 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A J LeachJ D Mathews
Jun 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A J Clavo-SánchezJ A Córdoba-Doña
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G A SyrogiannopoulosN G Beratis
Mar 27, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A D HarrisM H Samore
Aug 29, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G V Doern
Mar 27, 2002·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B N KimY S Kim
May 1, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paul H Edelstein
Jun 23, 2004·Emerging Infectious Diseases·Keith S KayeYehuda Carmeli
Apr 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Otto G VanderkooiUNKNOWN Toronto Invasive Bacterial Disease Network
Jun 21, 2005·Emerging Infectious Diseases·Keith P Klugman, John R Lonks
Jun 21, 2005·Emerging Infectious Diseases·Galia BarkaiRon Dagan
Jun 29, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gary V DoernSusan Beekmann

❮ Previous
Next ❯

Citations

Dec 27, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C Angebault, A Andremont
Oct 30, 2009·The Journal of Antimicrobial Chemotherapy·Shiona K GlassRita Finley
Apr 14, 2011·Fukushima Journal of Medical Science·Ayumi MatsumotoMitsuaki Hosoya
Feb 23, 2012·Fukushima Journal of Medical Science·Ayumi MatsumotoMitsuaki Hosoya
Nov 23, 2006·The Medical Clinics of North America·Gary V Doern
Sep 15, 2015·Pediatric Pulmonology·Lilliam AmbroggioSamir S Shah
Apr 5, 2013·Clinical Microbiology Reviews·Vered SchechnerMitchell J Schwaber
Jan 6, 2012·The Journal of Bone and Joint Surgery. British Volume·L A PoultsidesE Salvati
Nov 30, 2018·Current Drug Targets·Irene Anton-SalesDana Kralisch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
N DanemanToronto Invasive Bacterial Diseases Network
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Otto G VanderkooiToronto Invasive Bacterial Disease Network
© 2022 Meta ULC. All rights reserved